Posts Tagged ‘heart valves’

OnXLTI prepares to sell On-X Plus 1.5 Aortic Heart Valve

On-X LTI prepares European sales force to sell On-X® Plus 1.5™ Aortic Heart Valve “While the On-X® Plus 1.5™ Aortic Heart Valve represents a new paradigm by which clinicians can manage their patients on a reduced dose of warfarin, we are proud to note that On-X has been successfully selling mechanical valves in Europe since…

Read More

“I couldn’t be more pleased….”

It's been 14 months since my aortic valve replacement and implant of the On-X mechanical valve.  I couldn't be more pleased with the results.  In the last year, I've averaged walking 3-4 miles per day only missing a few days here and there on account of rain.  Even during this cold winter and last year,…

Read More

“I wanted the best….”

When I was told that I needed surgery to repair aneurysm on my Acending Aorta, I was extremely nervous to say the least. I then found that I had a bicuspid valve and that too needed to be replace. I was in the military so I really was at the mercy of what ever the…

Read More

“If I had it to do again would I choose an On-X valve? ABSOLUTELY”

In October of 2010, I was diagnosed with a congenital atrial valve defect requiring surgery. My surgeon and cardiologist were both extremely detailed in what was needed and gave me the opportunity to research each option and then meet with the surgeon again to agree on the time, process etc. After researching the mechanical valve…

Read More

On-X LTI Launches Innovative Heart Valve Products

European Meeting in Barcelona The On-X aortic valve with an anatomic shaped sewing ring and ePTFE suture for repair of mitral valve chordae presented at EACTS AUSTIN, TX – October 29, 2012 – On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve…

Read More

On-X Life Technologies to Highlight

Reduced Anticoagulation Study Results, Long-Term and Patient Survival Data with the On-X heart valve at STS Meeting Interim results for PROACT Trial, two ten-year clinical research reports and several clinical reports indicating longer survival for mechanical valve patients available to surgeons at The Society of Thoracic Surgeons Meeting AUSTIN, TX – January 24, 2012 –…

Read More

On-X Heart Valve’s Exceptional Clinical Performance

Important Clinical Research Featuring the On-X Heart Valve to be Presented at The Biennial Meeting of the Society for Heart Valve Disease in Barcelona, Spain AUSTIN, Texas, Jun 27, 2011 (BUSINESS WIRE) — On-X(R) Life Technologies, Inc. (On-X LTI) announced today that four clinical trial reports, documenting the On-X(R) Prosthetic Heart Valve’s extraordinary performance, will be presented at the upcoming meeting of the Society for Heart Valve Disease in Barcelona, Spain being held June 25-28, 2011. The reports will include interim clinical results from the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT), which is being conducted in 36 major institutions in the United States, a comparison of the On-X heart valve with three competitive mechanical valves in Australia, a Ten-year Multiple Center European Study and a Ten-year Study in Poorly Controlled Anticoagulated Patients in South Africa

Read More

On-X LTI to Host Satellite Symposium

On-X LTI to Host Satellite Symposium at Society of Thoracic Surgeons (STS) Meeting New Considerations for Prosthetic Valve Choice” challenges current prosthetic heart valve trends AUSTIN, TX — January 25, 2011 — On-X® Life Technologies, Inc. (On-X LTI) announced today that it will host a Satellite Symposium during the Society of Thoracic Surgeons meeting in…

Read More

On-X LTI Receives FDA Approval for AAP

On-X LTI Receives FDA Approval for Aortic Valve with Vascutek Graft Innovative On-X aortic valve is now available with market-leading pre-attached Gelweave Valsalva™ Vascular Prosthesis AUSTIN, TX — January 21, 2011 — On-X® Life Technologies, Inc. (On-X LTI) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market…

Read More
Onxlti Responsive Menu
Menu